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The M2 protein from influenza A plays important roles in its viral cycle. It contains a
single transmembrane helix, which oligomerizes into a homotetrameric proton channel
that conducts in the low-pH environment of the host-cell endosome and Golgi apparatus,
leading to virion uncoating at an early stage of infection. We studied conformational
rearrangements that occur in the M2 core transmembrane domain residing on the lipid
bilayer, flanked by juxtamembrane residues (M2TMD21−49 fragment), upon its interaction
with amantadine drug at pH 5.5 when M2 is conductive. We also tested the role of
specific mutation and lipid chain length. Electron spin resonance (ESR) spectroscopy
and electron microscopy were applied to M2TMD21−49, labeled at the residue L46C
with either nitroxide spin-label or Nanogold® reagent, respectively. Electron microscopy
confirmed that M2TMD21−49 reconstituted into DOPC/POPS at 1:10,000 peptide-to-lipid
molar ratio (P/L) either with or without amantadine, is an admixture of monomers,
dimers, and tetramers, confirming our model based on a dimer intermediate in the
assembly of M2TMD21−49. As reported by double electron-electron resonance (DEER), in
DOPC/POPS membranes amantadine shifts oligomer equilibrium to favor tetramers, as
evidenced by an increase in DEER modulation depth for P/L’s ranging from 1:18,000 to
1:160. Furthermore, amantadine binding shortens the inter-spin distances (for nitroxide
labels) by 5–8 Å, indicating drug induced channel closure on the C-terminal side.
No such effect was observed for the thinner membrane of DLPC/DLPS, emphasizing
the role of bilayer thickness. The analysis of continuous wave (cw) ESR spectra of
spin-labeled L46C residue provides additional support to a more compact helix bundle
in amantadine-bound M2TMD 21−49 through increased motional ordering. In contrast
to wild-type M2TMD21−49, the amantadine-bound form does not exhibit noticeable
conformational changes in the case of G34A mutation found in certain drug-resistant
influenza strains. Thus, the inhibited M2TMD21−49 channel is a stable tetramer with a
closed C-terminal exit pore. This work is aimed at contributing to the development of
structure-based anti-influenza pharmaceuticals.
Keywords: influenza M2 proton channel, amantadine, protein-drug interactions, proton channel inhibition, DEER
spectroscopy, ESR, protein-membrane interactions
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INTRODUCTION
Influenza pandemics cause serious health concerns for humans
and for depletion of livestock. To control and suppress
influenza infections, a good understanding of the fundamental
mechanisms underlying the structure and function of proteins
that play critical roles in the viral cycle is needed. In influenza
A virus one such essential protein is M2, which is a small
97 amino acid integral membrane protein containing a single
transmembrane helix (Figure 1A). In lipid membranes, M2
monomers oligomerize with their transmembrane parts forming
a four-helix bundle (Figure 1B). The tetramer exhibits proton
channel activity (Lamb et al., 1985; Sugrue and Hay, 1991).
After virus internalization, M2 activates at the low pH (5 to
6) of the host cell endosome, resulting in a proton influx that
acidifies the viral interior leading to uncoating of the virion and
release of the viral RNAs. In the process of replication, the M2
channel function is to support the transport of newly synthesized
viral proteins through the Golgi apparatus by equilibrating the
low intra-Golgi pH with that of the cytoplasm. The functional
proton channel unit is a tetramer of M2 transmembrane domains
(M2TMD) containing residues 22–46 (Ma et al., 2009). Two
residues H37 and W41 are known to provide a unidirectional
proton current; H37 shuttles the proton through the channel by
altering its protonation state, whereas W41 serves as the channel
gate (Okada et al., 2001; Wang et al., 2011).
Because of its role in virus proliferation, M2 is a target for
drug development. Several pharmaceutical products have been
developed to inhibit the M2 channel activity and more are
under development. Amantadine (Figure 1D) and rimantadine
are the best-studied M2 channel blockers (Hay et al., 1985;
Jing et al., 2008). It is essential to understand the modes of
interaction of these drugs with M2 that lead to inactivation. It is
currently accepted that both amantadine and rimantadine bind
to the central pore of the M2 transmembrane domain (M2TMD)
obstructing the access to theH37 selectivity filter (Jing et al., 2008;
Wang et al., 2011). Increased binding affinity of amantadine at
neutral or basic pH, compared to acidic pH, was attributed to
the change in the protonation state of H37, suggesting that this
residue participates in drug binding (Salom et al., 2000). Most of
the atomic-level structural studies on M2TMD-drug complexes
are at basic pH (Hu et al., 2007; Cady et al., 2010), which do not
represent the acidic environment of the endosome and the active
state of the M2 channel. The crystal structure of amantadine-
bound M2TMD tetramer at low pH 5.3 and in detergent micelles
provides insights into how the drug might inhibit the channel
function in low pH environment (Stouffer et al., 2008). However,
the structural information on drug-free M2TMD at low pH
is very limited and it is unclear how the inhibition of the
M2 channel under these conditions may occur. Moreover, one
could reasonably expect that the actual inhibition mechanism
in a lipid bilayer could be very different from what is seen in
detergent.
In this study, we sought to gain insights into the structural
basis underlying inhibition of the M2 proton channel.
Particularly, our focus is on the M2 oligomeric state and
the conformational response of the C-terminal pore of M2TMD
to amantadine drug binding at low pH (pH 5.5). To this
end, we applied double electron-electron resonance (DEER)
spectroscopy (Milov et al., 1984a; Borbat and Freed, 2007,
2014; Pannier et al., 2011; Jeschke, 2012) to the spin-labeled
peptide containing M2TMD and its N- and C-terminal flanking
residues—M2TMD21−49 (Figure 1C). The peptide, spin-labeled
with methanethiosulfonate nitroxide spin label (MTSL) at
position L46C, was reconstituted either into DOPC/POPS
or DLPC/DLPS lipid membranes, both prepared in 85:15
molar ratio of non-charged to charged lipid. This work is a
continuation of our previous DEER study of this system where
we found that the M2TMD21−49 tetrameric channel assembles
via a dimer intermediate (Georgieva et al., 2015). In the present
work, we focused on the effect of amantadine (hydrochloride)
on M2TMD21−49 conformations for peptide-to-lipid molar
ratios (P/L) ranging from 1:18,800 to 1:160. In the presence of
amantadine we observe conspicuous changes in the recorded
DEER signals in DOPC/POPS membranes for all P/L’s.
The binding of the drug shifts the M2TMD21−49 oligomer
equilibrium toward greater content of tetramers, as concluded
based on the substantial increase of the DEER signal modulation
depth, which increases with oligomeric number (Milov et al.,
1984b; Bode et al., 2007; Borbat and Freed, 2007; Jeschke
et al., 2009; Bhatnagar et al., 2012; Georgieva et al., 2013,
2015). Consequently, the tetramers must be stronger bound
than in the absence of amantadine. Moreover, in the presence
of amantadine, the inter-spin distances measured by DEER
are shorter by some 5–8 Å compared to the case without
amantadine, all other conditions being equal. Thus, binding
of amantadine induces closure of the M2TMD C-terminal
pore, thereby producing inactive M2 channels. Notably, as
opposed to the wild type M2TMD21−49, in the case of peptide
carrying the G34A drug-resistant mutation (Nguyen and Le,
2015) we did not observe any significant amantadine-induced
structural rearrangements at the C-terminus. This indicates
that just the binding of amantadine is insufficient for blocking
proton conductivity of the M2 proton channel, but a large
helix rigid-body movement or bending may be required to
squeeze the bundle, thereby closing the proton exit gate.
Furthermore, we found that in the membranes of DLPC/DLPS,
which are thinner than those of DOPC/POPS, the assembly
of M2TMD21−49 oligomers was much less efficient, and the
effect of amantadine was almost nonexistent. This emphasizes
the importance of lipid bilayer thickness and the tuning of its
properties in the regulation of the assembly and functioning of
M2 protein.
In addition, we applied electron microscopy (EM) to
M2TMD21−49 peptide, labeled with a gold nanoparticle reagent
(Nanogold R©) at the same L46C residue and reconstituted
into DOPC/POPS bilayers at P/L of 1:10,000. Although we
do not quantitatively characterize the oligomeric fractions in
this very dilute system, the EM micrographs obtained clearly
establish the presence of M2TMD21−49 monomers, dimers, and
tetramers both in the presence and absence of amantadine,
thereby confirming the model based on a strongly-bound dimer
intermediate as determined by our previous DEER study on the
M2-channel assembly pathway (Georgieva et al., 2015).
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FIGURE 1 | Influenza A M2 protein. (A) The domain organization of
full-length M2 encompasses the transmembrane domain (TMD) comprised of
residues 25–46 shown in green. (B) The structure of M2TMD tetramer
reported by X-ray crystallography (PDB 3C9J): The TM helices are further
away at the C-terminus; Amantadine (in red) is bound to the central pore of
M2TMD channel. The Cβ-atoms of residue L46, which was substituted for
cysteine in this work, are depicted as blue spheres. The lipid bilayer was
added for clarity. (C) M2TMD21−49 peptides (wt and G34A mutant) used in
this work: The residues corresponding to the TMD are in green, whereas the
N- and C-terminal juxtamembrane residues are in black. In the second
peptide, the alanine residue at position 34 is in red. The L46C residue used for
spin-labeling is in enlarged font. (D) The amantadine hydrochloride molecule.
MATERIALS AND METHODS
Influenza A M2 Peptide Synthesis and
Spin-Labeling
Wild type (wt) and G34Amutant ofM2TMD21−49 peptides (with
the sequences DSSDPLVVAASIIG[A]ILHLILWILDRCFFK,
L46C), synthesized commercially (GenScript Inc., USA) to the
purity higher than 98%, were received as powders. All procedures
for solubilizing and spin-labeling to the efficiency well above
90% (perhaps as high as 98%) were performed as described
previously (Georgieva et al., 2015). However, the final buffer
contained 50mM MES (2-(N-morpholino)ethanesulfonic acid)
as compared to 25mM used in the earlier work (Georgieva
et al., 2015). Consequently, the final buffer composition was
1mM β-DDM (n-Dodecyl β-D-maltoside), 50mM MES
pH 5.5, 150mM NaCl. The comparison of the DEER data
for samples with 25mM and 50mM MES showed they
were nearly identical. The M2TMD21−49 peptides were
spin-labeled with S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-
3-yl)methyl-methanesulfonothioate spin label (MTSL, Toronto
Research Chemicals). Spin-labeled peptide concentration after
free spin-label removal was 100µM prior reconstitution into
lipid membranes.
Preparation of Lipid Membranes and
M2TMD21−49 Peptide Reconstitution
All lipids were purchased from Avanti Polar Lipids. Procedures
were carried out as described in Georgieva et al. (2015).
Chloroform solutions of DOPC/POPS (1,2-dioleoyl-sn-glycero-
3-phosphocholine:1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
L-serine) (di-18:1 PC/16:0/18:1 PS) and DLPC/DLPS
(1,2-dilauroyl-sn-glycero-3-phosphocholine:1,2-dilauroyl-
sn-glycero-3-phospho-L-serine, di-12:0 PC/di-12:0 PS) at 85:15
molar ratio of uncharged-to-charged lipid were mixed, dried
under vacuum for at least 6 h, and then dissolved in 50mMMES,
pH 5.5, 150mM NaCl to the final total lipid concentration of
30mM. Spin-labeled wt and G34A peptides were then added to
the lipids. The samples of wt peptide were prepared in several
peptide-to-lipid molar ratios (P/L). The ratios were 1:18,800,
1:9400, 1:4100, 1:2300, 1:1650, 1:1300, 1:820, 1:500, 1:235, and
1:160 for DOPC/POPS; and 1:1300, 1:500, 1:160 for DLPC/DLPS.
In addition three samples of spin-labeled G34A peptide were
prepared in DOPC/POPS for P/L’s of 1:1300, 1:500, and 1:160.
Reacting M2TMD21−49 with Amantadine
Stock solution of 100mM amantadine hydrochloride
(amantadine) from Sigma-Aldrich was prepared in 50mM
MES, 150mM NaCl, and subsequently added to samples of
wt and G34A mutant of M2TMD21−49 for all P/L’s and lipid
compositions studied to a final concentration of 2mM, i.e.,
ca. 5 mol% drug-to-lipid ratio, similarly to previous studies
(Thomaston et al., 2013). To ensure uniform distribution of
amantadine, the samples were extensively vortexed, frozen in
liquid N2 and thawed to room temperature (RT) twice. After
the last thaw, the samples were kept for 2min at RT before
flash-freezing them in liquid N2 for DEER measurements.
The whole procedure for reacting M2TMD21−49 samples with
amantadine took about 4min, well within the requirements for
efficient binding (Salom et al., 2000). Additionally, samples with
P/L’s of 1:4100 and 1:2300 were incubated with amantadine at
RT for 2 h after the last thaw to test the effect of longer reaction.
Their respective DEER signals had no detectable dependence on
the incubation time (Supplementary Figure 1).
Preparation of Samples for DEER and cw
ESR Measurements
The following types of samples were used for DEER
measurements: (i) DOPC/POPS-reconstituted wt M2TMD21−49
in the presence of 2mM amantadine for all P/L’s ranging
from 1;18,800 to 1:160; (ii) Amantadine-free wt M2TMD21−49
for P/L’s of 1:9400, 1:4100, 1:1200, 1:1300, 1:500, and 1:160
in DOPC/POPS membranes; (iii) G34A M2TMD21−49 in
DOPC/POPS with and without 2mM amantadineand P/L’s
1:1300, 1:500, and 1:160; (iv) wt M2TMD21−49 in DLPC/DLPS
membranes at P/L’s 1:1300, 1:500, and 1:160 without and with
amantadine. All samples for DEERmeasurements had 20% (w/v)
glycerol as a cryoprotectant (Georgieva et al., 2015). Sample
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size was 20µL in a 2.5mm O.D. Pyrex tube. The samples were
flash-frozen and stored in liquid nitrogen for measurements.
The following samples were used for cw ESR measurements:
(i) wt M2TMD21−49 in DOPC/POPS with and without
amantadine at P/L’s of 1:4100, 1:1300, 1:500, and 1:160; and
(ii) magnetically diluted at 1:6 molar ratio of spin labeled to
unlabeled wt M2TMD21−49 in DOPC/POPS, either with or
without amantadine, at P/L of 1:160. All samples for cw ESR
measurements had no glycerol. All samples for DEER and
majority of samples for cw ESR were prepared and measured in
duplicates.
DEER Measurements and Inter-Spin
Distance Reconstruction
DEER measurements were carried out at 60 K using a home-
built pulse ESR spectrometer operated at 17.3 GHz in Ku band
(Borbat et al., 1997). The standard four-pulse DEER sequence
(Pannier et al., 2011) used for detection pi/2-pi-pi pulse sequence
with respective pulse widths of 16, 32, 32 ns; a 32 ns pi-
pulse was used for pumping. This is our preferred setup for
the case of more than two coupled spins (Georgieva et al.,
2013). The separation between the detection and pump pulse
frequencies was 70 MHz. The detection pulses were applied at
the low-field edge of the nitroxide spectrum. Typical dipolar
evolutions times were in 1.4–2µs range, with signal averaging
time being 2–4 h in most cases, except for the smallest P/L’s
(1:4100 to 1:18,800), where it was increased to 12–24 h The
signal background of the raw DEER data was removed in
the standard way (Georgieva et al., 2015) by approximating
the latter part of the logarithm of the signal by a second
degree polynomial and subtracting it out, followed by proper
normalization and origin shift (Supplementary Figures 1, 2).
This procedure of background subtraction produced maximum
±2.5% error in the modulation depth for the smallest P/L’s, as
estimated previously (Georgieva et al., 2015). Taking into account
all typical experimental uncertainties, such as introduced in the
course of sample preparation and due to, finite reproducibility
of resonator tuning and DEER experimental parameters, we
accepted more conservative error margins of ±5%. Inter-spin
distances were reconstructed from the DEER data, background
corrected and normalized as described above and in our previous
work (Georgieva et al., 2015), by using the L-curve Tikhonov
regularization method (Chiang et al., 2005a) refined when
necessary by the maximum entropy method (Chiang et al.,
2005b). It should be noted that distances distributions are plotted
up to the upper range of 8 nm, which is beyond ∼6 nm imposed
by the length of data record (∼2µs, except the cases of the largest
L/P). This mostly serves to show that baseline fit is good enough
by not producing large spurious peaks beyond 6 nm. In some
cases, the reconstructed distance distributions were modeled by
fitting them to a sum of two Gaussians using a non-linear least-
square (NLLS) curve fitting algorithm as implemented in the
OriginLab 8.0 software package (OriginLab, Inc.).
cw ESR Measurements
The cw ESR measurements were performed at X-band
(microwave frequency ca. 9.4 GHz) on liquid samples at room
temperature (ca. 25◦C), and also at controlled temperatures
of 21◦C and 40◦C, as well as on frozen samples at −100◦C
(Supplementary Figures 3, 4). The cw ESR spectra were recorded,
using the Bruker ELEXIS E500 (Bruker, Billerica, USA) ESR
spectrometer equipped with ER 4122-SHQE super-high Q
resonator and ER4131VTVT-31 variable temperature accessory.
The microwave power and modulation amplitude were 1.26mW
and 2.2 G for the measurements on liquid samples and 50µW
and 2 G for frozen samples. For estimation of spin-label dynamic
parameters the cw ESR spectra for samples of wt M2TMD21−49
in DOPC/POPS membrane for P/L’s of 1:1300 and 1:500, both
with and without amantadine, were fitted using the NLLS
program (Budil et al., 1996) and the MOMDmodel.
Concentration Profile Analysis
This analysis was performed using the NLLS procedure based
on Levenberg-Marquardt algorithm implemented in MATLAB R©
(Georgieva et al., 2015).
Attaching Gold Nanoparticle Tag to wt
M2TMD21−49 Peptide
The detergent-reconstituted peptide was mixed with
monomaleimido functionalized gold nanoparticles (1.4 nm
Monomaleimido Nanogold R© from Nanoprobes) at 1:1 molar
ratio in the buffer of 100mM sodium phosphate pH 6.0, 5mM
EDTA and 1mM DDM, and incubated at RT for 6 h. When
attached, Nanogold particles add ca. 15 kDa to the molecular
weight of the monomeric peptide, thus producing a labeled
peptide of average molecular weight >18 kDa. Hence, a tetramer
with all subunits labeled should have a molecular weight
exceeding 60 kDa. To remove the unreacted Nanogold, the
sample was washed at least five times with the buffer of 25mM
MES pH 5.5, 150mM NaCl and 1mM DDM using 30 kDa
MWCO concentrator and keeping the peptide concentration in
the range where the tetramer is dominant, i.e., above peptide to
detergent molar ratio (P/D) of 1:40 (Georgieva et al., 2015). Then
the peptide sample was diluted with the buffer to a P/D, which
was higher than 1:3500 where peptide is mostly monomeric and
dimeric and concentrated using 10 kDa MWCO filter to remove
the monomeric unlabeled peptides. This procedure was repeated
five times. Thus, we are confident that the final sample was
highly enriched in Nanogold labeled M2TMD21−49 peptide. The
final peptide concentration was estimated from the Nanogold
particle extinction coefficient of 156,000 M−1cm−1 at 420 nm (as
specified by the manufacturer).
Thereafter, the labeled peptide was mixed with Triton-100
destabilized DOPC/POPS (85:15 molar ratio) lipid suspensions
in the buffer of 25mM MES pH 5.5 and 150mM NaCl followed
by incubation at RT for 1 h. The P/L was ca. 1:10,000 within
the accuracy of peptide concentration determination. Then the
sample was dialyzed for 48 h at 4◦C. Liposomes were prepared
using a mini extruder (Avanti Polar Lipids, Inc.) and 0.4 micron
polycarbonate membrane.
Electron microscopy
Negative stain TEM: 5µL of sample consisting of lipid vesicles
with Nanogold labeled M2TMD21−49, prepared either with or
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without amantadine, were placed onto freshly carbon-coated and
plasma treated hexagonal EM grids (300 mesh, Ted Pella, Inc.,
Redding, CA, USA) and stained with 1% Uranyl acetate (UA).
Thereafter, digital micrographs were collected with a JEOL -
JEM2100 LaB6 equipped transmission electron microscope
(TEM) (JEOL, Ltd) operated at 200 kV and equipped with a
4 × 4 US4000 CCD camera (Gatan) at a low dose conditions
(<16 e−/Å2), and at 2.8 Å/pixel final resolution (×54,323 final
magnification, Supplementary Figure 5).
Cryo-EM: Freezing was done using Lacey 200 mesh EM grids
(TedPella, Inc). Plasma clean 15 s, BF = 0, BT = 4 s. Sample
volume was 2.5µL. The excess liquid was blotted and the grids
quickly plunged (∼2000◦C/s) into liquid ethane, cooled down
by liquid nitrogen to obtain amorphous ice in a Vitrobot Mark
IV (FEI, Millsboro, OR, USA). The grids were transferred and
observed at liquid nitrogen temperature. Digital micrographs
were recorded on TEM JEOL JEM2200 TEM (JEOL Ltd)
operated at 200 kV and equipped with a field emission gun energy
filter and 4× 4 K US4000 CCD camera (Gatan, Inc), at low- dose
conditions (15 e−/Å2) and 2.9 Å/pixel resolution.
RESULTS
Binding of Amantadine Shifts the
Equilibrium to More Stable M2TMD21−49
Tetramers in DOPC/POPS Membranes
We studied the effect of drug-binding on the structure of
M2TMD21−49 in DOPC/POPS by recording the DEER time-
domain signals for a series of spin-labeled samples, which
were either amantadine-free or contained 2mM amantadine.
Experiments were conducted over a broad range of P/L’s from
1:18,800 up to 1:160. We observed that for the same P/L binding
of amantadine led to an increase in the DEER modulation
depth 1 (the DEER signal amplitude at zero time in our plots)
compared to the amantadine-free sample (Figures 2A,B). This
effect was detected for all P/L’s studied; although to a different
extent (Figures 2A–C), with a maximum increase of 23–30% at
P/L’s between 1:1300 and 1:4100 (Figure 2C).
Here we remind the reader that DEER modulation depth is
defined as 1(p) = 1 − DEER(t =∞)/DEER(t = 0) and directly
depends on the number of interacting spins as 1 (p, N) = [1
− (1 − p)N−1], where p is the fraction of spins flipped by the
pump pi-pulse and N is the number of interacting spins (Milov
et al., 1984b; Bode et al., 2007; Jeschke et al., 2009; Bhatnagar
et al., 2012; Borbat and Freed, 2014). We used this spin-counting
capacity of DEER spectroscopy to elucidate the mechanism of
assembly of M2TMD21−49 in our previous work(Georgieva et al.,
2015).
As we previously established, within the broad range
of P/L’s studied, the drug-free M2TMD21−49 exists as an
admixture of monomers, dimers, and tetramers, with the
population of each of these oligomeric forms being strongly
dependent on P/L (Georgieva et al., 2015). In this work, the
increase in the DEER modulation depth shows that binding of
amantadine dramatically shifts the equilibrium of M2TMD21−49
oligomeric species toward the higher order oligomers, enriching
tetramers. We have no reason to believe that other intermediate
oligomers, i.e., trimers, are formed, since their existence was
not detected by any technique previously employed. Presence
of very short distance in amantadine-free or amantadine-
bound conformations of M2TMD21−49, which would reduce
the modulation depth, could also be ruled out, since no
such distances were detected by low temperature cw ESR
(Georgieva et al., 2015; Supplementary Figure 4). To confirm
our hypothesis, we fitted the experimental DEER modulation
depth concentration profiles (Supplementary Figure 6), for the
samples with amantadine to a two-stage equilibrium that is
monomer
k2d
←→ dimer
k4d
←→ tetramer, as previously described
(Georgieva et al., 2015). There was good agreement between
the model and the experiment data (Figure 2D). Thus, in the
presence of amantadine, we obtained dissociation constants k2d
(expressed as mole fraction, MF) of 39 ppm and k4d of 42 ppm.
For comparison, these constants for drug-free M2TMD21−49
were 15·ppm (P/L ∼ 1:65,000) and 448·ppm (P/L of 1:2230),
as previously determined (Georgieva et al., 2015). The 10-fold
reduction of k4d in the presence of amantadine and the close
values of k2d and k4d shows that binding of amantadine strongly
stabilizes M2TMD21−49 tetramer, whereas the values of k2d
remain reasonably close in both cases. The closeness of the two
dissociation constants in the case of amantadine results in a
greater uncertainty in the k2d value determination, so it would
be premature to construe that amantadine has any effect or even
binds to dimers. Our observations are in the agreement with the
previously reported stabilizing effect of amantadine on M2TMD
tetramer in dodecylphosphocholinemicelles at both high and low
pH (Salom et al., 2000).
To further support our DEER results, we conducted electron
microscopy (EM) experiments on M2TMD21−49 fully-labeled at
the same L46C residue with monomaleimido-gold nanoparticles
(Nanogold R©). Two methods were used—negative staining TEM
and cryo EM. The obtained data for sample of M2TMD21−49 in
DOPC/POPS bilayers at a P/L of ∼1:10,000 with and without
amantadine are shown in Figures 3A,B, respectively. In the
EM micrographs one can distinguish monomers, dimers, and
tetramers of nanogold-labeled M2TMD21−49, albeit obtaining
quantitative information about the fraction of these oligomeric
species at such a high dilution was outside the range of
our EM experiments. Given the careful iterative procedure
for the removal of unlabeled peptide and unreacted nanogold
particles (Experimental Procedures), we are confident that no
significant amount of unlabeled M2TMD21−49 was present in
the samples, therefore the type of gold nanoparticle clusters,
discernable in EM micrographs, faithfully reports on the type of
M2TMD21−49 oligomeric species present under the conditions of
our experiment.
In DOPC/POPS Membranes the C-Terminal
Pore of M2TMD Closes Upon Binding of
Amantadine
In addition to increased modulation depth of the recorded
DEER signals for the samples with amantadine, we observed
faster decaying DEER signals (Figure 2A) in spin-labeled wt
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FIGURE 2 | (A) Background subtracted and normalized (as detailed in the supplement, cf. Supplementary Figure 2) DEER data for spin-labeled M2TMD21−49 in
DOPC/POPS membranes at pH 5.5 and four P/L’s, namely 1:160, 1:500, 1:1300, and 1:4100. The data without and with (2mM) amantadine are in red and black,
respectively. Samples with amantadine were incubated for 2min at RT after two cycles of freeze/thaw, (cf. Experimental Procedures). Only the early 1.1µs of the
DEER signals are shown for clarity. (B) The DEER modulation depths for samples without and with amantadine for P/L’s 1:160, 1:500, 1:1300, 1:2300, 1:4100, and
1:9400. The error bars correspond to the maximum uncertainty of ±5% in the modulation depth estimation (cf. Experimental Procedures). (C) Relative increase in
DEER modulation depth upon addition of amantadine for the P/L’s in (B). (D) DEER signal modulation depth concentration profile (open gray squares) is plotted vs.
M2TMD21−49 molar fraction in DOPC/POPS lipid mixture with amantadine. The solid line is the fit of these data to the equilibrium model based on tandem
momomer↔dimer↔tetramer. The obtained equilibrium constants, k2d, k4d are 39·10
−6MF and 42·10−6MF, pointing to stronger bound tetramers than in the
absence of the drug.
M2TMD21−49. These signals correspond to inter-spin distances
shorter by some 5–8 Å than those in the absence of the drug,
all other conditions being equal (Figure 4A). Furthermore, the
distance distributions for amantadine-boundM2TMD21−49 were
significantly narrower than those for the drug-free peptide
(Figure 4A). To further address how these structural transitions
may be coupled with channel inhibition, we analyzed in more
detail our experimental inter-spin distances distributions for
samples without and with amantadine and within the context of
existing structural data. Specifically, we compared the distances
from our experiment to those derived based on the available
structures. As this manuscript was being finalized, the structure
of amantadine-free M2TMD at pH 5.5 has emerged, solved
by X-ray crystallography in the lipid cubic phase (Thomaston
et al., 2015). We thus employed this structure as a template to
rationalize our DEER distance distributions by fitting them to a
weighted sum of two Gaussians in a ratio of 4:2 (proximal-to-
lateral distances). In the fittings, the initial guesses for Gaussian
means corresponded to the Cβ-Cβ distances in the crystal
structure, which are 24.2 Å (proximal) and 34.2 Å (lateral)
in the four-fold symmetric tetramer (PDB code 4QKM, cf.
Figure 4B). Certainly this model represented the experimental
distance distributions well, and from the fittings we obtained r1
= 23 Å with σ1 = 9 Å, and r2 = 34 Å with σ2 = 9 Å, where r and σ
are the Gaussians mean and standard deviation. These r1 and r2
values agree well with the expected rlateral to rproximal 21/2 ratio
in a homotetramer with the four-fold symmetry, as discussed
previously (Dalmas et al., 2012). These fittings along with the
experimental distance distributions for P/L’s of 1:160 and 1:1300
are shown in Figure 4C. Notably, the same set of parameters
used in the fittings for P/L of 1:1300 did not account for
noticeable content of longer range experimental distances, which
we previously attributed to M2TMD21−49 dimers (Georgieva
et al., 2015). Thus, the tetramer produced shorter distances, both
proximal and lateral, than the dimer, which most likely is due to
a more compact nature of the four-helix bundle.
Next, we aimed to characterize the conformation of the C-
terminal of M2TMD channel when bound to the amantadine
channel blocker. To do so, we first used the crystal structure
of M2TMD tetramer with amantadine bound to the central
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FIGURE 3 | EM micrographs of M2TMD21−49 nanogold labeled at position L46C and reconstituted into DOPC/POPS membranes. The data shown in
(A,B) are those without and with 2mM amantadine, respectively. In both cases the P/L was 1:10,000. The blue boxes are the areas contained inside green circles
magnified by a factor of 20 to emphasize monomers, dimers and tetramers of M2TMD21−49.
pore at pH 5.3 (PDB ID 3C9J) (Stouffer et al., 2008). However,
our experimental distances were significantly shorter and the
distributions were considerably narrower than those in the crystal
structure (Figure 4). Obviously, in this structure the helices splay
apart at the C-terminal forming a wide open pore, considerably
wider than in the structures observed at elevated pH (Schnell
and Chou, 2008; Andreas et al., 2010; Sharma et al., 2010). Also,
the arrangement of helices, including helix rotation, provides
a degree of asymmetry in the C-terminal with four distinct
proximal distances of 18.9 Å, 26.9 Å, 26.7Å and 30.4 Å, and two
lateral distances of 38.9 Å and 33.8 Å between the L46 Cβ atoms in
M2TMD (Figure 4B). This apparent disagreement between the
DEER-derived and crystallography determined distances could
be a result of lipid bilayer effects on the M2TMD structure (see
below), but could also be because of the G34A mutation in the
crystalized construct (Stouffer et al., 2008).
To address this discrepancy, we tested how the distances from
highly symmetric and much more closed ssNMR structure of
amantadine-bound M2TMD channel in DMPC membranes at
pH 7.5 (Cady et al., 2010) match our results (Figure 4B). Again,
we fit the DEER distances for spin-labeled residue L46C to a sum
of two Gaussians with contributions 4:2, and obtained r1 = 20.8
Å with σ1 = 6.7 Å, and r2 = 29 Å with σ2 = 7 Å, which are very
close to the Cβ-Cβ distances, i.e., 18.6 Å and 26.4 Å, in the NMR
structure, and agree well with a highly symmetric homotetramer.
In this case the Gaussian fittings better represented the majority
of experimental distances even at P/L of 1:1300, as expected
from the increase in the population of M2TMD21−49 tetramers.
Furthermore, the Gaussian widths (σ), extracted from the fittings,
i.e., representing the widths of the distance distributions, were
narrower by ca. 2 Å in the presence of amantadine than those
without drug, and the ratio between the mean proximal and
lateral distance was closer to that of a tetramer with a four-fold
symmetry. This indicates that amantadine-stabilized structure is
less heterogeneous and more symmetric.
To further establish the reason for the discrepancy between
the crystal structure and our results, we measured DEER
distances between L46C residues in M2TMD21−49 carrying
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FIGURE 4 | DEER distances reveal a large conformational motion of M2TMD21−49 channel leading to the closure of C-terminal pore triggered by
amantadine binding. (A) Inter-spin distances for spin-labeled L46C reconstructed from the DEER time-domain signals shown in Figure 2 for P/L’s 1:160, 1:500,
1:1300, and 1:4100. Data for M2TMD21−49 samples without and with 2mM amantadine are plotted in red and black, respectively. A shift by 5–8 Å to shorter
distances was observed in all cases upon binding of amantadine. (B) Positions of residues L46 Cβ-atomsin M2TMD tetramer based on published amantadine-bound
structures at pH 5.5 in lipid cubic phase (X-ray); pH 5.3 in detergent (X-ray); and in lipid at pH 7.5 (ssNMR). Contrary to our observations, in the amantadine-bound
low-pH crystal structure, the C-terminal of M2TMD tetramer is widely open and asymmetric. (C) The experimental distances for P/L’s 1:160 and 1:1300 are shown
along with the two-Gaussian fit (in blue). (D) A compendium of Cβ-Cβ distances based on the available atomic-resolution structures (shown in C) and those extracted
from the two-Gaussian fitting of DEER distances.
the mutation G34A. Indeed these distances were distributed
between 20 and 40 Å, which is a significantly broader range
than in wt M2TMD21−49 and is closer to the predictions based
on MTSL rotamer libraries (Polyhach et al., 2011) generated
for low-pH crystal structure (Stouffer et al., 2008) (Figure 5).
Strikingly, binding of amantadine had marginal if any effect
on M2TMD C-terminal conformation, manifested by almost
unchanged time-domain DEER signals and correspondent
inter-spin distances. This result points to a potentially
critical functional role of the G34 residue, including drug
resistance. Furthermore, the G34A mutation itself did not
reduce the M2TMD21−49 self-association, based on the DEER
modulation depth. In fact, the DEER modulation depths
for P/L’s 1:1300 and 1:160 were even slightly greater than
those for wt peptide under equal conditions (Figures 3A,
5), but answering the question whether this mutation has
any tetramer stabilizing effect is beyond the scope of this
study.
The Hydrophobic Thickness of Lipid Bilayer
Influences the Structure of M2TMD21−49
and Its Interaction with Amantadine
Recognizing the role of the lipid bilayer hydrophobic thickness
on the structure and inhibition of M2TMD21−49 was an
extra goal of the current study. We reported that self-
association of M2TMD21−49 is more efficient in membranes
with hydrophobic thickness matching the 28.5 Å length of
the M2TMD transmembrane helix, such as DOPC/POPS,
compared to thinner membranes of DLPC/DLPS (Georgieva
et al., 2014). Accordingly, we studied the effect of amantadine
onM2TMD21−49 reconstituted in DLPC/DLPS at 85:15 mol% vs.
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FIGURE 5 | Background-subtracted normalized time-domain DEER
data (left) and reconstructed distance distributions (right) for
spin-labeled L46C residue in G34A mutant of M2TMD21−49
reconstituted in DOPC/POPS membranes are shown for P/L’s of 1:160
and 1:1300. Only the early 1.1µs of the DEER signals are shown for clarity.
The data with and without amantadine are solid lines drawn in black and red,
respectively. Inter-spin distances do not change upon the addition of
amantadine, and they are in the range of 20 to 40 Å. For comparison, the
distance distributions for wt M2TMD21−49 are shown in the upper right panel
as pink and gray flooded areas. In this case the inward movement is
pronounced.
DOPC/POPS taken at the same ratio. Interestingly, in the thinner
membranes the effect of amantadine on the shape of DEER
signals for the same P/L’s, particularly on their modulation depth,
was almost negligible (Figure 6, left). Moreover, in DLPC/DLPS
the shapes of DEER signals were significantly different from
those in DOPC/POPS, leading to longer reconstructed inter-
spin distances for spin-labeled residue L46C (Figure 6, right).
This suggests that M2TMD helix may adjust to the hydrophobic
mismatch by increasing its tilt angle in agreement with similar
finding by NMR (Hu et al., 2011). Finally, in DLPC/DLPS the
DEER distances for P/L’s of 1:1300, 1:500, and 1:160 do not
change upon the addition of 2mM amantadine. Consequently,
amantadine-induced tetramer stabilization and closure of C-
terminal proton exit pore does not occur in this particular
membrane environment or these effects are rather small to be
conclusive.
DISCUSSION
In the current study, we aimed to characterize in greater
detail the conformational transition from active to inhibited
M2TMD channel and the oligomeric profile under low pH
conditions (pH 5.5), which is close to those found in
endosomes, where the M2 proton channel is conductive.
Understanding in detail how the inhibition occurs is desirable
FIGURE 6 | Effect of amantadine on DEER data is almost negligible for
WT M2TMD21−49 residing in DLPC/DLPS membranes. Background
subtracted and normalized DEER time-domain data (left) and corresponding
distances (right) for spin-labeled residue L46C at P/Ls of 1:160, 1:500, and
1:1300 are shown. Only the early 1.1µs of the DEER signals are shown for
clarity. No detectable or very small changes in the DEER signals and
corresponding distances were observed upon addition of amantadine. Longer
incubation with amantadine (1 h at RT) did not produce any additional effect on
the DEER data (gray signal in the middle left panel for P/L of 1:500) compared
to standard incubation of ∼4min.
for designing new and more efficient anti-influenza drugs. Yet,
our present knowledge is insufficient. Therefore, we studied
the M2TMD21−49 construct reconstituted in DOPC/POPS
and DLPC/DLPS membranes, with or without M2 channel
blocker amantadine, as well as for the case of the G34A
mutation.
In our previous work we found that the transmembrane
domain of influenza A M2 protein assembles into a tetramer
via a tight dimer intermediate (Georgieva et al., 2015). Here, the
results from DEER spectroscopy (Figure 2) and EM (Figure 3)
show that just as for the drug-free channel, in the presence
of amantadine M2TMD21−49 there is also a mixture of
monomers, dimers, and tetramers when residing in bilayers of
DOPC/POPS, whose hydrophobic thickness closely matches the
length of the M2 transmembrane helix (Kucˇerka et al., 2005;
Georgieva et al., 2015). Indeed, our observations agree with a
dimeric intermediate, which was previously predicted by MD
simulations of the M2TMD assembly process (Carpenter et al.,
2008).
Furthermore, our results strongly suggest that the inhibition
of theM2TMD proton channel occurs via drug-induced tetramer
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stabilization and C-terminal channel closure. The detected
increase in the DEER modulation depth in the presence of
amantadine vs. no amantadine (Figure 2) within a broad
range of P/L’s from 1:18,800 to 1:160 shows that the binding
of drug shifts the equilibrium toward a greater content of
tetramers in agreement with previous observations for M2TMD
in dodecylphosphocholinemicelles (Salom et al., 2000). Using the
detailed DEER-based analysis of oligomer equilibria in M2TMD
assembly pathway (Georgieva et al., 2015), we estimated the
monomer↔dimer and dimer↔ tetramer dissociation constants
kd2 and kd4 of 39.10−6 and 42.10−6 MF, respectively, in the
presence of the drug. The very close values of these constants
points toward a much stronger amantadine-bound tetrameric
species, compared to the amantadine-free system for which we
previously reported kd2 and kd4 of 15·10−6 MF (P/L∼1:65,000)
and 448·10−6 MF (P/L of 1:2230) respectively (Georgieva et al.,
2015). The M2TMD tetramer dissociation at acidic pH, observed
by us (Georgieva et al., 2015) and others (Salom et al., 2000),
was ascribed to increased protonation of the H37 tetrad and
electrostatic repulsion (Salom et al., 2000). On the contrary,
when amantadine binds to M2TMD its charged ammonium
group forms a hydrogen bond with the neutral imidazole side
chain of the histidine residue, thus expunging the proton and
reducing the protonation state of the system (Gandhi et al., 1999;
Salom et al., 2000; Hu et al., 2007) resulting in a more stable
tetramer.
In addition to M2TMD21−49 tetramer stabilization, the
observed shift at the C-terminus toward shorter distances
by 5–8 Å with the addition of amantadine reveals that in
DOPC/POPS membranes M2TMD21−49 tetramer undergoes
large scale conformational rearrangements leading to C-terminal
pore closure. To the best of our knowledge, this is the first
observation of such a large conformational change from active
to inhibited forms of M2TMD at conditions of low pH (pH
5.5). Moreover, our experiments on M2TMD21−49 G34A mutant
strongly suggest the critical role of this glycine residue in M2
channel inhibition. This is also supported by the presence of
G34A mutation in some amantadine resistant influenza strains
(Nguyen and Le, 2015). That is, the ability of M2TMD tetramer
to perform proton exit gate closure is inhibited by substituting the
G34 residue for alanine and this could be the main reason for the
drug-resistance of this mutant. Since the drug-bound M2TMD
construct carrying this mutation was previously crystallized
(Stouffer et al., 2008), we assume that the observed effect is
not a result of abolished amantadine binding. It is likely that
the G34 residue serves as a “gating hinge,” similar to ligand-
and voltage-gated K+ channels (Magidovich and Yifrach, 2004;
Chakrapani and Perozo, 2007; Hulse et al., 2014). It should
be noted that a kink and a varying extent of conformational
heterogeneity at this position in the M2 TM helix was observed
by NMR for M2 channel for a range of conditions including
the binding of drug at high pH (Hu et al., 2006, 2011; Cady
et al., 2010), and it was also predicted from MD simulations (Yi
et al., 2009). However, altering the drug-binding site such that
it prevents the interaction of amantadine with H37 to change
the total protonation state of the histidine tetrad could also be
possible.
The detailed DEER-derived distance analysis by fitting to
two-Gaussians (Figure 4C, upper panel) suggests that non-
inhibited M2TMD21−49 tetramer is conformationally more
heterogeneous than the amantadine-bound one, and possibly
even slightly asymmetric at acidic pH, in agreement with
previous observations at higher pH’s (Sharma et al., 2010;
Andreas et al., 2015), and this could be a prerequisite for
channel function. On the contrary, the similar distance analysis
in the presence of amantadine shows that the M2TMD21−49
tetramers, which are almost fully assembled at P/L’s greater
than 1:1300, are highly symmetric and more conformationally
restricted. This is also supported by the cw EPR measurements
taken on the samples of spin-labeled M2TMD21−49 with and
without the addition of amantadine, from which we found by
NLLS spectral fitting that binding of the drug increases the
local ordering of the nitroxide spin-label, thereby contributing
additional broadening to the MOMD lineshape (Supplementary
Figure 3). This indicates that local conformational changes
leading to a drug-induced channel confinement restrict the spin-
label conformations. All these results taken together suggest
that the inhibited form of M2TMD21−49 channel is a highly
symmetric compact tetramer.
The observed inefficient M2TMD21−49 assembly into
tetramers in thinner DLPC/DLPS membrane, which is based
on the much reduced DEER modulation depth, i.e., 1 <
0.3 at the highest 1:160 P/L used (Figure 6), as well as
the lack of effect of amantadine on the inter-spin distance
distributions, demonstrates the importance of the match of
bilayer hydrophobic thickness on M2TMD self-association
and possibly function, as is the case with other membrane
proteins (Killian, 1998). It should be noted that in the absence
of any data on the binding of amantadine to M2TMD21−49
oligomers in DLPC/DLPS bilayers, any reduced affinity to the
drug cannot be entirely ruled out. It is expected that protein-drug
interaction is dependent on favorable arrangement of helices in
M2TMD21−49 oligomers. Thus, any unfavorable energetics of
M2TMD oligomer insertion into the lipid bilayer could produce
penalties for both efficient tetramer formation and drug binding.
Indeed, the different degree of assembly of M2TMD21−49 in
lipid bilayers differing in hydrophobic thickness raises a question
about the oligomeric state of M2 as well as about the mechanisms
of inhibition on the secretory pathway of this protein when
residing in membranes of cellular organelles and cell walls with
unequal thickness (Mitra et al., 2004). It would be important in
the future to conduct studies clarifying these issues.
Our study, aimed at contributing to the development of M2-
based anti-influenza pharmaceuticals, adds to our knowledge of
howM2TMD channel conformational states and its environment
are related to its function and inhibition. Our spectroscopic
data shed light on channel conformations as a function of
pH, membrane morphology, the presence of anti-M2 drug, and
mutations. Particularly, in the extensively studied topic of the
interaction with amantadine, we were able to reveal the drug-
induced C-terminus squeezing motion associated with channel
closure at pH 5.5, and the absence thereof in the case of G35A
mutation. Notably, unambiguous spectroscopic information on
the conformational response of M2TMD to binding of anti-M2
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drug was provided under pH conditions similar to those in the
endosome.
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